NASDAQ:SYBX
Synlogic Inc Stock News
$1.80
+0.0100 (+0.559%)
At Close: May 13, 2024
Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory
06:30am, Tuesday, 02'nd Feb 2021
CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- A collaboration between MIT Voigt Lab and Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biol
Do Options Traders Know Something About Synlogic (SYBX) Stock We Don't?
09:47am, Thursday, 14'th Jan 2021
Investors need to pay close attention to Synlogic (SYBX) stock based on the movements in the options market lately.
Synlogic Outlines Upcoming Clinical Milestones
06:30am, Monday, 11'th Jan 2021
CAMBRIDGE, Mass., Jan. 11, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today outlined significa
5 Biopharma Stocks Making Big Moves Monday
11:33am, Monday, 14'th Dec 2020
Even as the broader market trades higher in reaction to the availability of the first coronavirus vaccine under emergency use authorization, a slew of biopharma stocks are moving on company-specific u
Why Is It Moving? Looking At Synlogic's Price Action Today
10:04am, Monday, 14'th Dec 2020
Synlogic's (NASDAQ: SYBX) stock is trading up 17.18% to a price of $2.76. The stock's current volume for the day is 15.18 million, which is approximately 1159.03% of its previous 30-day average volume
CAMBRIDGE, Mass., Dec. 14, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced SYNB1891
Synlogic Appoints Michael Heffernan to its Board of Directors
06:30am, Wednesday, 09'th Dec 2020
CAMBRIDGE, Mass., Dec. 9, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appoi
CAMBRIDGE, Mass., Dec. 7, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that it w
Synlogic to Present at Upcoming Virtual Banking Conference
06:30am, Wednesday, 18'th Nov 2020
CAMBRIDGE, Mass., Nov. 18, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoi
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q3 2020 Results - Earnings Call Transcript
12:22pm, Saturday, 07'th Nov 2020
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q3 2020 Results - Earnings Call Transcript
Recap: Synlogic Q3 Earnings
08:42am, Thursday, 05'th Nov 2020
Shares of Synlogic (NASDAQ:SYBX) moved higher by 10.11% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 7.69% year over year to ($0.36), which
Synlogic Reports Third Quarter 2020 Financial Results and Provides Business Update
06:30am, Thursday, 05'th Nov 2020
CAMBRIDGE, Mass., Nov. 5, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial
